Millions of patients each year undergoing PCI are implanted with drug-eluting or bare-metal stents. Comparisons between the types of stents have been limited, although a recent randomized study in Norway showed similar outcomes between the two categories.

The American College of Cardiology recently published findings in JACC: Basic to Translational Science that show the pace of innovation and investment in developing new cardiovascular therapeutics has decreased over the past 22 years.

Stents have long been the preferred treatment for reopening blocked arteries in patients who’ve suffered a heart attack or other heart conditions. But new research suggests that physicians may be able to forgo stent procedures and instead give patients anti-thrombotic medications.

A prospective, observational cohort study found that a significant decrease in 180-day all-cause mortality among patients with non-ST-elevation MI (NSTEMI) was associated with increased use of an invasive coronary strategy.

Eating more spinach and oranges while pregnant could help women prevent heart conditions from developing in their children, new research says.

A registry analysis found that patients with non-valvular atrial fibrillation who received dabigatran etexilate (Pradaxa) had low rates of stroke, major bleeding and life-threatening bleeding after two years of treatment.

After 12 months of follow-up, 96 percent of patients who received the Micra transcatheter pacing system (Medtronic) had no major complications.

For patients with systolic heart failure that was not caused by ischemic heart disease, implanting prophylactic implantable cardioverter-defibrillators (ICDs) did not reduce the long-term rate of death of any cause compared with patients who did not receive an ICD, according to a randomized trial.